Finnish Institute for Health and Welfare, later referred to as THL, request your tender for Antidotes and poisoning medical products to the rescEU project. The Scope of procurement is described in more detail in Annex 1. The procurement is divided in thirteen (13) lots. Tender may be submitted for one or several lots. - LOT 1: Dimercaptopropane sulfonate (DMPS) 100 mg tablets/capsules - LOT 2: Prussian blue, i.e. Iron(III) hexacyanoferrate(II) 500 mg tablets/capsules - LOT 3: Succimer (Dimercaptosuccinic acid, DMSA) 200 mg tablets/capsules - LOT 4: Dimercaptopropane sulfonate (DMPS) 50 mg/ml (5 ml per vial/ampoule) - LOT 5: Calcium trisodium pentetate (Ca-DTPA) 1 g / 5 ml (5 ml per vial/ampoule) - LOT 6: Zinc trinatrium pentetate (Zn-DTPA) 1055 mg / 5 ml (5 ml per vial/ampoule) - LOT 7: Obidoxime 250 mg/ml (1 ml per vial/ampoule) - LOT 8: Pralidoxime 2 g / 100 ml (100 ml per vial/ampoule) - LOT 9: Hydroxocobalamin 5 g (5 g per vial/ampoule) - LOT 10: Fomepizole 5 mg/ml (20 ml per vial/ampoule) - LOT 11: Calcium edetate (Ca-EDTA) 50 mg/ml (10 ml per vial/ampoule) - LOT 12: Calcium gluconate 100 mg/ml (10 ml per vial/ampoule) - LOT 13: Silver sulfadiazine 10 mg/g (50 g - 100 g per tube/container) The minimum requirements for the articles is described in Annex 1.1. The contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the contract has been signed by contracting parties and expires when all contractual duties of the contract have been performed. Estimated quantity for the product in described in Annex 6 (restricted to security classification level IV, TL IV). Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Contract Annex 3 Security annex Annex 4 Description of the Handi service Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 6 Estimated quantity (restricted, TL IV) Annex 7 Confidentiality commitment Please note that the numbering of the annexes differs between the Contract and the Call for Tenders.
Määräaika
Tarjousten vastaanottamisen määräaika oli 2023-11-24.
Hankinta julkaistiin 2023-10-20.
hankintailmoitus (2023-10-20) Kohde Hankinnan laajuus
Otsikko: Antidotes and poisoning medical products / 2024-2025
Reference number: THL/5139/2.02.06/2023
Lyhyt kuvaus:
“Finnish Institute for Health and Welfare, later referred to as THL, request your tender for Antidotes and poisoning medical products to the rescEU project....”
Lyhyt kuvaus
Finnish Institute for Health and Welfare, later referred to as THL, request your tender for Antidotes and poisoning medical products to the rescEU project. The Scope of procurement is described in more detail in Annex 1.
The procurement is divided in thirteen (13) lots. Tender may be submitted for one or several lots.
- LOT 1: Dimercaptopropane sulfonate (DMPS) 100 mg tablets/capsules
- LOT 2: Prussian blue, i.e. Iron(III) hexacyanoferrate(II) 500 mg tablets/capsules
- LOT 3: Succimer (Dimercaptosuccinic acid, DMSA) 200 mg tablets/capsules
- LOT 4: Dimercaptopropane sulfonate (DMPS) 50 mg/ml (5 ml per vial/ampoule)
- LOT 5: Calcium trisodium pentetate (Ca-DTPA) 1 g / 5 ml (5 ml per vial/ampoule)
- LOT 6: Zinc trinatrium pentetate (Zn-DTPA) 1055 mg / 5 ml (5 ml per vial/ampoule)
- LOT 7: Obidoxime 250 mg/ml (1 ml per vial/ampoule)
- LOT 8: Pralidoxime 2 g / 100 ml (100 ml per vial/ampoule)
- LOT 9: Hydroxocobalamin 5 g (5 g per vial/ampoule)
- LOT 10: Fomepizole 5 mg/ml (20 ml per vial/ampoule)
- LOT 11: Calcium edetate (Ca-EDTA) 50 mg/ml (10 ml per vial/ampoule)
- LOT 12: Calcium gluconate 100 mg/ml (10 ml per vial/ampoule)
- LOT 13: Silver sulfadiazine 10 mg/g (50 g - 100 g per tube/container)
The minimum requirements for the articles is described in Annex 1.1.
The contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
The contract period shall enter into force once the contract has been signed by contracting parties and expires when all contractual duties of the contract have been performed.
Estimated quantity for the product in described in Annex 6 (restricted to security classification level IV, TL IV).
Please note that all times given in the Call for Tender refer to local time in Finland.
Call for Tenders, Annexes:
Annex 1 Scope of the procurement
Annex 1.1 Minimum requirements
Annex 2 Contract
Annex 3 Security annex
Annex 4 Description of the Handi service
Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022)
Annex 6 Estimated quantity (restricted, TL IV)
Annex 7 Confidentiality commitment
Please note that the numbering of the annexes differs between the Contract and the Call for Tenders.
Näytä lisää
Sopimustyyppi: supplies
Tuotteet/palvelut: Muut lääkkeet📦 Tietoa eristä
Tämä sopimus on jaettu osiin ✅
Yhdelle tarjoajalle myönnettävien erien enimmäismäärä: 13
Tarjouksia voidaan jättää enintään yhtä erää varten: 13
1️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Dimercaptopropane sulfonate (DMPS) 100...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Dimercaptopropane sulfonate (DMPS) 100 mg
- Oral solid dosage forms
- Active pharmaceutical ingredient: Dimercaptopropane sulfonate (DMPS)
- Strength: 100 mg
- Pharmaceutical form: tablets/capsules.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Näytä lisää
Lisätuotteet/palvelut: Farmaseuttiset tuotteet📦
Kesto: 17 (MONTH)
Jäljempänä oleva aikataulu on ilmaistu kuukausina.
Myöntämisperusteet
Hinta ✅
Laatukriteeri (nimi): Quality 1: Registered shelf life of the product
Laatukriteeri (nimi): Quality 2: Delivery time to the customer’s warehouse
Laatukriteeri (nimi): Quality 3: Language of packaging and product information leaflet
Laatukriteeri (nimi): Quality 4: Transportation temperature and excursions
Otsikko
Erän tunnistenumero: LOT-0001
2️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Prussian blue, i.e. Iron(III)...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Prussian blue, i.e. Iron(III) hexacyanoferrate(II) 500 mg tablets/capsules
- Oral solid dosage forms
- Active pharmaceutical ingredient: Prussian blue, i.e. Iron(III) hexacyanoferrate(II)
- Strength: 500 mg
- Pharmaceutical form: tablets/capsules.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
3️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Succimer (Dimercaptosuccinic acid, DMSA)...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Succimer (Dimercaptosuccinic acid, DMSA) 200 mg tablets/capsules
- Oral solid dosage forms
- Active pharmaceutical ingredient: Succimer (Dimercaptosuccinic acid, DMSA)
- Strength: 200 mg
- Pharmaceutical form: tablets/capsules.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
4️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Dimercaptopropane sulfonate (DMPS) 50...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Dimercaptopropane sulfonate (DMPS) 50 mg/ml (5 ml per vial/ampoule)
- Parenteral product (intravenous administration)
- Active pharmaceutical ingredient: Dimercaptopropane sulfonate (DMPS)
- Strength: 50 mg/ml
- Container size: 5 ml per vial/ampoule.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
5️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Calcium trisodium pentetate (Ca-DTPA) 1 g...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Calcium trisodium pentetate (Ca-DTPA) 1 g / 5 ml (5 ml per vial/ampoule)
- Parenteral product (intravenous administration)
- Active pharmaceutical ingredient: Calcium trisodium pentetate (Ca-DTPA)
- Strength: 1 g / 5 ml
- Container size: 5 ml per vial/ampoule.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
6️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Zinc trinatrium pentetate (Zn-DTPA) 1055...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Zinc trinatrium pentetate (Zn-DTPA) 1055 mg / 5 ml (5 ml per vial/ampoule)
- Parenteral product (intravenous administration)
- Active pharmaceutical ingredient: Zinc trinatrium pentetate (Zn-DTPA)
- Strength: 1055 mg / 5 ml
- Container size: 5 ml per vial/ampoule.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
7️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Obidoxime 250 mg/ml (1 ml per...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Obidoxime 250 mg/ml (1 ml per vial/ampoule)
- Parenteral product (intravenous administration)
- Active pharmaceutical ingredient: Obidoxime
- Strength: 250 mg/ml
- Container size: 1 ml per vial/ampoule.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
8️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Pralidoxime 2 g / 100 ml (100 ml per...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Pralidoxime 2 g / 100 ml (100 ml per vial/ampoule)
- Parenteral product (intravenous administration)
- Active pharmaceutical ingredient: Pralidoxime
- Strength: 2 g / 100ml
- Container size: 100 ml per vial/ampoule.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
9️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Hydroxocobalamin 5 g (5 g per...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Hydroxocobalamin 5 g (5 g per vial/ampoule)
- Parenteral product (intravenous administration)
- Active pharmaceutical ingredient: Hydroxocobalamin
- Strength: 5 g
- Container size: 5 g per vial/ampoule.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
1️⃣0️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Fomepizole 5 mg/ml (20 ml per...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Fomepizole 5 mg/ml (20 ml per vial/ampoule)
- Parenteral product (intravenous administration)
- Active pharmaceutical ingredient: Fomepizole
- Strength: 5 mg/ml
- Container size: 20 ml per vial/ampoule.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
1️⃣1️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Calcium edetate (Ca-EDTA) 50 mg/ml (10 ml...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Calcium edetate (Ca-EDTA) 50 mg/ml (10 ml per vial/ampoule)
- Parenteral product (intravenous administration)
- Active pharmaceutical ingredient: Calcium edetate (Ca-EDTA)
- Strength: 50 mg/ml
- Container size: 10 ml per vial/ampoule.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
1️⃣2️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Calcium gluconate 100 mg/ml (10 ml per...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Calcium gluconate 100 mg/ml (10 ml per vial/ampoule)
- Parenteral product (intravenous administration)
- Active pharmaceutical ingredient: Calcium gluconate
- Strength: 100 mg/ml
- Container size: 10 ml per vial/ampoule.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
1️⃣3️⃣
Hankinnan kuvaus:
“The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Silver sulfadiazine 10 mg/g (50 g - 100 g...”
Hankinnan kuvaus
The subject of the procurement is article in accordance with the following requirements:
- The subject of tender: Silver sulfadiazine 10 mg/g (50 g - 100 g per tube/container)
- Cream on the skin for topical use
- Active pharmaceutical ingredient: Silver sulfadiazine
- Strength: 10 mg/g
- Container size: 50 g - 100 g per tube/container.
The minimum requirements of the article is described in more detail in Annex 1.1.
The delivery schedule for the articles is described in Annex 1.
Estimated quantity for the article is described in Annex 6 (restricted, TL IV).
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Menettely Toimenpiteen tyyppi
Avoin menettely ✅ Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2023-11-24 12:00:00 📅
Tarjousten avaamista koskevat ehdot: 2023-11-24 12:30:00 📅
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 6
Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot Taloudellinen ja rahoituksellinen asema
Luettelo ja lyhyt kuvaus valintaperusteista:
“Yearly turnover: Its (“general”) yearly turnover is as follows:
Year 2022: 1000000,00 EUR
Year 2021: 1000000,00 EUR” Osallistumisehdot
Luettelo ja lyhyt kuvaus olosuhteista:
“Enrolment in a relevant professional register: It is enrolled in the relevant professional registers kept in the Member State of its establishment.”
Luettelo ja lyhyt kuvaus olosuhteista:
“Enrolment in a trade register: It is enrolled in the relevant trade registers kept in the Member State of its establishment.” Sopimukseen liittyvät ehdot
Sopimuksen täytäntöönpanoehdot:
“For further details please see the documents of the Call for
Tenders.”
“The availability for the Annex 6 is restricted to security classification level IV, TL IV. THL will send the restricted Annex 6 to a representative of the...”
The availability for the Annex 6 is restricted to security classification level IV, TL IV. THL will send the restricted Annex 6 to a representative of the tenderer via encrypted email after THL has received the signed confidentiality commitment (Annex 7). Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/5139/2.02.06/2023 / Antidotes and poisoning medical products / 2024-2025". The message must contain name of the tenderer and email address to which the restricted Annex 6 is to be sent.
Näytä lisää Arvostelurunko
Nimi: Markkinaoikeus
Kansallinen rekisterinumero: 3006157-6
Postiosoite: Radanrakentajantie 5
Postinumero: 00520
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa🏙️
Maa: Suomi 🇫🇮
Sähköposti: markkinaoikeus@oikeus.fi📧
Puhelin: +358 295643300📞
URL: http://www.oikeus.fi/markkinaoikeus🌏 Tietoa sähköisistä työnkuluista
Sähköinen laskutus hyväksytään
Sähköistä tilaamista käytetään
Sähköistä maksua käytetään
Lähde: OJS 2023/S 204-643223 (2023-10-20)